The Zantac recall is quickly turning into a landslide as CVS pulled Zantac and its generics from its shelves and countries from Korea to Bangladesh asked...
LabFinder.com, a convenient online platform for patients to schedule their laboratory and radiology tests and access results, has announced the launch of its newest digital healthcare service,...
Ambry Genetics® (Ambry), a leading clinical genetic testing company, announced today the launch of +RNAinsight™, a major advancement in genetic testing. +RNAinsight enables clinicians – for the...
Marken announced today that six Marken branches will become Cell and Gene Centers of Excellence in 2019. In addition, a full-time, global team has been appointed to develop and support the...
Delphi Behavioral Health Group, a leading nationwide provider of addiction and detox treatment programs, announced today the opening of its newest full-service in-patient mental health treatment...
Celltrion announced that it is launching TemixysTM in the U.S. which were approved in November by U.S. Food and Drug Administration (FDA). Celltrion anticipates Temixys to be available...
MMS Holdings, Inc. (MMS) – an award-winning, data-focused CRO – celebrated another successful collaboration with Oracle Health Sciences and a specialized Oncology pharmaceutical company. MMS will share...
Medtronic has secured approval from the US Food and Drug Administration (FDA) to start an early feasibility study (EFS) for its Intrepid transcatheter mitral valve replacement...
CivaTech Oncology has secured approval from the US Food and Drug Administration (FDA) for its new skin cancer therapy product called CivaDerm. CivaDerm is a temporary...
UK-based medical technology company LivaNova has enrolled the first patient in RECOVER clinical study to evaluate Vagus Nerve Stimulation (VNS) Therapy for Treatment-Resistant Depression (TRD). RECOVER...
ElevateBio, a Cambridge-based biotechnology holding company, today announced it has established and launched HighPassBio, a company dedicated to advancing novel targeted T cell immunotherapies. The company’s...
AstraZeneca presented results on Monday for a trial of its Lynparza drug against prostate cancer, which it hopes could lead to wider regulatory approval for the...
Drugmakers have embraced artificial intelligence — using computers to analyze reams of data and then make predictions or recommendations. Germany’s Bayer has been testing how the...
Coker Group is excited to announce our strategic partnership with ProCARE Portal. In looking to strengthen our position within the growing compensation technology market, we found...
IQ-AI Ltd said it has received the regulatory green light in America for its StoneChecker software, which is used to assess kidney stones. Imaging Biometrics, the...
Copyright © 2024 Medical Buyer